Amphiregulin is an EGF related growth factor and was originally isolated from the conditioned media of a PMA-treated MCF-7 human breast carcinoma cell line. It is mainly expressed numerous carcinoma cell lines and the epithelial cells of various human tissues including colon, stomach, breast, ovary, kidney, etc. Synthesized as a transmembrane protein, Amphiregulin’s extracellular domain is proteolytically processed to release the mature protein. There are 6 conserved cysteine residues, which form 3 intramolecular disulfide bonds essential for biological activity. Amphiregulin signals through the EGF/TGF-a receptor, and stimulates growth of keratinocytes, epithelial cells and some fibroblasts. It also inhibits the growth of certain carcinoma cell lines. Mutations in this encoded protein are associated with a psoriasis-like skin phenotype.
Reference
1. Giusti C, Desruisseau S, Ma L, et al. 2003. Int J Cancer, 105: 769-78
2. Solic NandDavies DE. 1997. Exp Cell Res, 234: 465-76
3. Michalopoulos GKandKhan Z. 2005. Gastroenterology, 128: 503-6
4. Eckstein N, Servan K, Girard L, et al. 2008. J Biol Chem, 283: 739-50
5. Higginbotham JN, Demory Beckler M, Gephart JD, et al. 2011. Curr Biol, 21: 779-86.